1. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia
   Jing-dong Zhou et al, 2016, Tumor Biology CrossRef
2. Correlation between circulating miR‐122 and prognosis of chronic HBV‐related liver failure
   Wei Jing Wang et al, 2016, Journal of Digestive Diseases CrossRef
3. Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition
   Guoliang Sun et al, 2021, Frontiers in Molecular Biosciences CrossRef
4. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia
   Ting-juan Zhang et al, 2018, Pathology - Research and Practice CrossRef
5. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling
   Gang Chen et al, 2017, Cancer Cell International CrossRef
6. Homeobox Genes and Hepatocellular Carcinoma
   Kwei-Yan Liu et al, 2019, Cancers CrossRef
7. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review
   Yoshiaki Mizuguchi et al, 2016, Hepatology Research CrossRef
8. DLX Genes: Roles in Development and Cancer
   Yinfei Tan et al, 2021, Cancers CrossRef
9. Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia
   Jing-Dong Zhou et al, 2015, Biochemical and Biophysical Research Communications CrossRef